AAAAAA
Results:
1-13
|
Results: 13
Authors:
Largeron, M
Mesples, B
Gressens, P
Cecchelli, R
Spedding, M
Le Ridant, A
Fleury, MB
Citation: M. Largeron et al., The neuroprotective activity of 8-alkylamino-1,4-benzoxazine antioxidants, EUR J PHARM, 424(3), 2001, pp. 189-194
Authors:
Betdeder, D
Cecchelli, R
Dehouck, MP
Fenart, L
Citation: D. Betdeder et al., Reaching the neurons, BIOFUTUR, 2000(196), 2000, pp. 28-31
Authors:
Cecchelli, R
Fenart, L
Buee-Scherrer, V
Dehouck, B
Descamps, L
Duhem, C
Torpier, G
Dehouck, MP
Citation: R. Cecchelli et al., In vitro models of the blood-brain barrier and their use in drug development, BLOOD-BRAIN BARRIER AND DRUG DELIVERY TO THE CNS, 2000, pp. 65-75
Authors:
Olivier, JC
Fenart, L
Chauvet, R
Pariat, C
Cecchelli, R
Couet, W
Citation: Jc. Olivier et al., Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity, PHARM RES, 16(12), 1999, pp. 1836-1842
Authors:
Cecchelli, R
Dehouck, B
Descamps, L
Fenart, L
Buee-Scherrer, V
Duhem, C
Lundquist, S
Rentfel, M
Torpier, G
Dehouck, MP
Citation: R. Cecchelli et al., In vitro model for evaluating drug transport across the blood-brain barrier, ADV DRUG DE, 36(2-3), 1999, pp. 165-178
Authors:
Fenart, L
Casanova, A
Dehouck, B
Duhem, C
Slupek, S
Cecchelli, R
Betbeder, D
Citation: L. Fenart et al., Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier, J PHARM EXP, 291(3), 1999, pp. 1017-1022
Authors:
Fillebeen, C
Dehouck, B
Benaissa, M
Dhennin-Duthille, I
Cecchelli, R
Pierce, A
Citation: C. Fillebeen et al., Tumor necrosis factor-alpha increases lactoferrin transcytosis through theblood-brain barrier, J NEUROCHEM, 73(6), 1999, pp. 2491-2500
Authors:
Girod, J
Fenart, L
Regina, A
Dehouck, MP
Hong, GY
Scherrmann, JM
Cecchelli, R
Roux, F
Citation: J. Girod et al., Transport of cationized anti-tetanus Fab ' 2 fragments across an in vitro blood-brain barrier model: Involvement of the transcytosis pathway, J NEUROCHEM, 73(5), 1999, pp. 2002-2008
Authors:
Carpentier, M
Descamps, L
Allain, F
Denys, A
Durieux, S
Fenart, L
Kieda, C
Cecchelli, R
Spik, G
Citation: M. Carpentier et al., Receptor-mediated transcytosis of cyclophilin B through the blood-brain barrier, J NEUROCHEM, 73(1), 1999, pp. 260-270
Authors:
Bernoud, N
Fenart, L
Moliere, P
Dehouck, MP
Lagarde, M
Cecchelli, R
Lecerf, J
Citation: N. Bernoud et al., Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid, J NEUROCHEM, 72(1), 1999, pp. 338-345
Authors:
Fillebeen, C
Descamps, L
Dehouck, MP
Fenart, L
Benaissa, M
Spik, G
Cecchelli, R
Pierce, A
Citation: C. Fillebeen et al., Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier, J BIOL CHEM, 274(11), 1999, pp. 7011-7017
Authors:
Trottein, F
Descamps, L
Nutten, S
Dehouck, MP
Angeli, V
Capron, A
Cecchelli, R
Capron, M
Citation: F. Trottein et al., Schistosoma mansoni activates host microvascular endothelial cells to acquire an anti-inflammatory phenotype, INFEC IMMUN, 67(7), 1999, pp. 3403-3409
Authors:
Chopineau, J
Robert, S
Fenart, L
Cecchelli, R
Lagoutte, B
Paitier, S
Dehouck, MP
Domurado, D
Citation: J. Chopineau et al., Monoacylation of ribonuclease A enables its transport across an in vitro model of the blood-brain barrier, J CONTR REL, 56(1-3), 1998, pp. 231-237
Risultati:
1-13
|